Oruka Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Oruka Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Oruka Therapeutics Inc.
Rating: 1.72225
Author: Trendlyne DVM scores

about

ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a poten...

33.00 -1.55 (-4.49%)

501.09% Gain from 52W Low

274.6K

XNAS Volume

XNAS 04 Feb, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Moderately Bullish

68.9 / 100

No estimates available

Oruka Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Oruka Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a poten...

501.09% Gain from 52W Low

SWOT Analysis

Oruka Therapeutics Inc Live Price Chart